Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder
Clinical trial NCT04337827 · TERMINATED
Trial details
- NCT number
- NCT04337827
- Sponsor
- Deepa Jagadeesh
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2022-06-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.